Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005815 | microtubule organizing center | 2 | 1 |
GO:0036064 | ciliary basal body | 3 | 1 |
GO:0097542 | ciliary tip | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HB20
Term | Name | Level | Count |
---|---|---|---|
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0006996 | organelle organization | 4 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0018095 | protein polyglutamylation | 7 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018200 | peptidyl-glutamic acid modification | 6 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0022607 | cellular component assembly | 4 | 1 |
GO:0030030 | cell projection organization | 4 | 1 |
GO:0030031 | cell projection assembly | 5 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044782 | cilium organization | 5 | 1 |
GO:0060271 | cilium assembly | 6 | 1 |
GO:0070925 | organelle assembly | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0120031 | plasma membrane bounded cell projection assembly | 6 | 1 |
GO:0120036 | plasma membrane bounded cell projection organization | 5 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.478 |
CLV_NRD_NRD_1 | 213 | 215 | PF00675 | 0.586 |
CLV_NRD_NRD_1 | 244 | 246 | PF00675 | 0.601 |
CLV_PCSK_FUR_1 | 210 | 214 | PF00082 | 0.535 |
CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.496 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.449 |
CLV_PCSK_PC1ET2_1 | 212 | 214 | PF00082 | 0.449 |
CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.488 |
CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.282 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.566 |
DEG_APCC_KENBOX_2 | 147 | 151 | PF00400 | 0.455 |
DOC_MAPK_gen_1 | 146 | 155 | PF00069 | 0.442 |
DOC_MAPK_RevD_3 | 1 | 16 | PF00069 | 0.607 |
DOC_PP4_FxxP_1 | 83 | 86 | PF00568 | 0.490 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.423 |
DOC_USP7_UBL2_3 | 46 | 50 | PF12436 | 0.531 |
DOC_WW_Pin1_4 | 197 | 202 | PF00397 | 0.390 |
LIG_14-3-3_CanoR_1 | 15 | 23 | PF00244 | 0.537 |
LIG_14-3-3_CanoR_1 | 226 | 236 | PF00244 | 0.558 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.511 |
LIG_EH_1 | 135 | 139 | PF12763 | 0.498 |
LIG_FHA_1 | 115 | 121 | PF00498 | 0.452 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.456 |
LIG_FHA_2 | 4 | 10 | PF00498 | 0.526 |
LIG_LIR_Apic_2 | 80 | 86 | PF02991 | 0.488 |
LIG_LIR_Apic_2 | 88 | 93 | PF02991 | 0.482 |
LIG_LIR_Gen_1 | 103 | 112 | PF02991 | 0.443 |
LIG_LIR_Gen_1 | 55 | 65 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 103 | 107 | PF02991 | 0.443 |
LIG_LIR_Nem_3 | 191 | 195 | PF02991 | 0.419 |
LIG_LIR_Nem_3 | 55 | 60 | PF02991 | 0.376 |
LIG_LYPXL_yS_3 | 126 | 129 | PF13949 | 0.496 |
LIG_PTB_Apo_2 | 17 | 24 | PF02174 | 0.534 |
LIG_PTB_Phospho_1 | 17 | 23 | PF10480 | 0.532 |
LIG_Rb_LxCxE_1 | 103 | 122 | PF01857 | 0.477 |
LIG_SH2_CRK | 23 | 27 | PF00017 | 0.626 |
LIG_SH2_STAP1 | 192 | 196 | PF00017 | 0.386 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.442 |
LIG_SH2_STAT5 | 195 | 198 | PF00017 | 0.303 |
LIG_SH3_3 | 134 | 140 | PF00018 | 0.442 |
LIG_SH3_3 | 200 | 206 | PF00018 | 0.457 |
LIG_SUMO_SIM_anti_2 | 176 | 182 | PF11976 | 0.442 |
LIG_TYR_ITIM | 102 | 107 | PF00017 | 0.371 |
LIG_TYR_ITIM | 124 | 129 | PF00017 | 0.410 |
MOD_CK1_1 | 235 | 241 | PF00069 | 0.490 |
MOD_CK1_1 | 32 | 38 | PF00069 | 0.519 |
MOD_CK2_1 | 73 | 79 | PF00069 | 0.632 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.626 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.440 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.279 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.480 |
MOD_GSK3_1 | 232 | 239 | PF00069 | 0.603 |
MOD_N-GLC_2 | 150 | 152 | PF02516 | 0.327 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.240 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.355 |
MOD_NEK2_1 | 236 | 241 | PF00069 | 0.538 |
MOD_PIKK_1 | 216 | 222 | PF00454 | 0.544 |
MOD_PKA_2 | 14 | 20 | PF00069 | 0.641 |
MOD_PKA_2 | 225 | 231 | PF00069 | 0.653 |
MOD_Plk_2-3 | 73 | 79 | PF00069 | 0.539 |
MOD_Plk_4 | 166 | 172 | PF00069 | 0.336 |
MOD_Plk_4 | 73 | 79 | PF00069 | 0.539 |
MOD_ProDKin_1 | 197 | 203 | PF00069 | 0.396 |
TRG_ENDOCYTIC_2 | 104 | 107 | PF00928 | 0.279 |
TRG_ENDOCYTIC_2 | 126 | 129 | PF00928 | 0.410 |
TRG_ENDOCYTIC_2 | 23 | 26 | PF00928 | 0.519 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5F3 | Leptomonas seymouri | 70% | 100% |
A0A1X0PB71 | Trypanosomatidae | 48% | 100% |
A0A3S7X866 | Leishmania donovani | 86% | 100% |
A0A422N4N2 | Trypanosoma rangeli | 50% | 99% |
A4IA77 | Leishmania infantum | 86% | 100% |
C9ZM32 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
E9B590 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
Q4Q2P3 | Leishmania major | 84% | 100% |
V5BQF3 | Trypanosoma cruzi | 51% | 100% |